People suffering from leprosy in Nigeria will finally receive crucial medications to treat their condition after a year of shortages, the World Health Organization (WHO) confirmed. With the country reporting over 2,000 new leprosy cases annually, the halt in drug supplies had significant repercussions, including the exacerbation of patients' health issues due to newly implemented testing regulations.
The WHO has coordinated the import of necessary medications from India, which are expected to arrive this Sunday. Leprosy, while curable with a combination of antibiotics, can lead to severe health complications such as nerve damage and disfigurement if left untreated. Patients in Nigeria have faced extended waits and have been discharged from hospitals without necessary treatments, raising concerns about potential spread of the disease due to ongoing transmission.
Dr. Samimu Msheliza, a medical advisor at the Nigerian branch of the Leprosy Mission, emphasized the urgency surrounding the provision of these medications: "We have thousands of newly diagnosed leprosy patients across various cities who are just waiting for this drug," he stated. The delay in provision has severely affected many, including Awwal Musa from Nasarawa state, whose condition worsened in the absence of treatment. "Before last year, my wounds were getting healed but now they are getting worse. The pain is worse," Musa lamented.
Nigeria's drug regulatory authority had implemented new laws aimed at mitigating the influx of counterfeit medications, but these regulations inadvertently led to critical treatment shortages. As the influx of leprosy drugs arrives, health officials stress the importance of resuming effective treatment to curb the disease's spread.
